Hormone replacement therapy study halted
Increased risk of breast cancer a factor, government says

Study: Estrogen-only therapy may raise ovarian cancer risk

NIH Asks Participants in Women's Health Initiative Estrogen-Alone Study to Stop Study Pills, Begin Follow-up Phase
Statement from Barbara Alving, M.D., Director of the Women's Health Initiative and Acting Director of the National Heart, Lung, and Blood Institute

Miller Curtis & Weisbrod, LLP
11551 Forest Central Drive
Suite 300
Dallas, Texas 75243
1.888.987.0005
mcwlawfirm.com

Morgan & Weisbrod
11551 Forest Central Drive
Suite 300 Dallas, TX 75243
Toll Free: 1.800.800.6353
morganweisbrod.com